Withdrawal of antidepressants does not impact the efficacy of COMP360 psilocybin therapy: results from a phase IIb randomised controlled trial

psilocybin (COMP360) - Compass Pathways

G.M. Goodwin1; M. Croal2; J. Chai-Rees3; L. Marwood2; S. Mistry3; A. Nowakowska2; H. Simmons3; J. Tsai2

Sep 30, 2023